Benserazide, a Cystathionine Beta-Synthase (CBS) Inhibitor, Potentially Enhances the Anticancer Effects of Paclitaxel Via Inhibiting the S-sulfhydration of SIRT1 and the HIF1-α/VEGF Pathway
Frontiers in Pharmacology（2024）
Key words
benserazide,paclitaxel,SIRT1,HIF1-alpha,VEGF,cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined